Seminars in Arthritis and Rheumatism

Article	Citations
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice	104
mRNA vaccines in the rheumatologist's future	76
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	75
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	71
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	70
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF	66
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	65
The Autoantibody response in rheumatoid arthritis; what makes it unique?	58
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	56
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	52
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	51
Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?	41
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	41
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	40
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	39
Response letter to the editor	37
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	36
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	35
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	34
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	33
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	32
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	32
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative	30
Immunotherapy in cancer	29
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	29

Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	29
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	28
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	27
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	27
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	27
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	26
The ASAS-OMERACT core domain set for axial spondyloarthritis	25
Psychological stress in rheumatoid arthritis: a systematic scoping review	25
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	25
Response letter to the Editor	24
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	24
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	24
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	23
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	23
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	22
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	22
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	22
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	22
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	22
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	22
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	22
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	22
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	22
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	21
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	21
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	21
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	21
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	20
Response to commentary on IgG4-related uveitis. A French cohort and literature review	20
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	20
Therapeutic approach to central nervous system involvement of Behçet's disease	20
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	20
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	20
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	20
Women with Rheumatoid Arthritis have similar rates of postpartum maternal outcomes compared to women without autoimmune disease	19
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	19
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	19
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	19
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	19
Sarcoidosis incidence after mTOR inhibitor treatment	19
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	18
Mechanisms of joint pain: Five short lessons from osteoarthritis	18
Comparative effectiveness of exercise programs for psychological well-being in knee osteoarthritis: A systematic review and network meta-analysis	18
Pathogenesis and targets in uveitis	18
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	18
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	18
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	18
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	18
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	18
Biologics in peripheral ulcerative keratitis	17

Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature	17
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	17
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	17
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	17
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	17
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	17
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	17
Juvenile and adult-onset scleroderma: Different clinical phenotypes	16
Monoclonal antibody and anti-cytokine biologics for Kawasaki disease: A systematic review and meta-analysis	16
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	16
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	16
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	16
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	16
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	16
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	15
Table of Contents	15
Comments on the article by Goldman et al.	15
Elderly-onset rheumatoid arthritis is a unique disease subset associated with poor overall outcomes: Response to the letter by Haroon and Ayamer	15
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	14
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	14
The shrinking toe sign in gout	14
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	14
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	14
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	14
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	14
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	14
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	14
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	14
Diagnostic value of different imaging features for patients with suspected gout: A network meta-analysis	13
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	13
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	13
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	13
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	13
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	13
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	13
Historical bioarcheological aspects of diffuse idiopathic skeletal hyperostosis in humans	13
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	13
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	13
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	13
Modelling long-term outcomes for patients with systemic lupus erythematosus	13
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	13
Acknowledgement of Referees	13
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	13
An analysis of the first relapse in giant cell arteritis using ultrasonography	13
Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity	12
Aortic disease in giant cell arteritis	12
Age of onset of rheumatoid arthritis and radiographic changes	12
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	12
The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	12
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	12
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study	12
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	12
Giant cell arteritis – New treatment targets at the horizon	12
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	12
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	12
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	12
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	12
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	12
Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis	12
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	12
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	12
How is early spondyloarthritis defined in the literature? Results from a systematic review	12
Predicting best treatment in rheumatoid arthritis	12
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	11
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome	11
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	11
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	11
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	11
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	11
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	11
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	11
Telemedicine in rheumatology care: A systematic review	11
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	11
Correspondence on “Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis” by Weisman et al.	11
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	11
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	11
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	11
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	11
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	11
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	11

Pregnancy outcomes in patients treated with belimumab: Report from real-world experience	10
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
Association between facet joint ankylosis and functional impairment in patients with radiographic axial spondyloarthritis	10
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	10
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies	10
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	10
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	10
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	10
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	10
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	10
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	10
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Joint and muscle inflammatory disease: A scoping review of the published evidence	10
Macrophages–Autoimmunity–Treatment option	10
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	10
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	10
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	10
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Corrigendum to ‘TNF-alpha inhibition for the treatment of cardiac sarcoidosis’ seminars in arthritis and rheumatism. 2020 Jun;50(3):546-552	10
Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds	10
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	9
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	9
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	9
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	9
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Systematic review of imaging tests to predict the development of rheumatoid arthritis in people with unclassified arthritis	9
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group	9
Polygenic risk scores	9
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	9
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	9
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	9
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	9
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	9
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Infection case of COVID-19 in patients with rheumatic diseases receiving biologic agents in Wuhan, China: A retrospective population-based analysis from a single center	9
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	9
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	9
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	9
Healthy dietary pattern and risk of rheumatoid arthritis: a systematic review and meta-analysis	9
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	9
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	8
Author Reply to Letter to the Editor	8
Factors associated with thrombosis in Behçet Syndrome: A systematic review and meta-analysis	8
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	8
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set	8
Moving urate-lowering therapy in gout beyond guideline recommendations	8
Navigating the path of progress: The OMERACT 2023 emerging leaders program	8
Referees	8
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study	8
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group	8
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extens	8
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)	8
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis	8
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy	8
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	8
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	8
Why most (but perhaps not all) DMARDs work equally well	8
An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare	8
Development of a prediction model for poor prognosis in childhood-onset Takayasu's arteritis	8
Development and evaluation of shared decision-making tools in rheumatology: A scoping review	7
Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis	7
Response to Dr. Wolfe	7
Do not ignore another risk factor of invasive fungal infections in patients with connective tissue disease	7
Information and communication technology-based patient education for autoimmune inflammatory rheumatic diseases: A scoping review	7
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration	7
Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis	7
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study	7
Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies	7
Post-hoc analysis of two gout remission definitions in a two-year randomized controlled trial of nurse-led versus usual gout care	7
Predictors of remission in people with axial spondyloarthritis: A systematic literature review	7
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020	7
One-year survival benefit of plasma exchange in idiopathic inflammatory myositis patients with progressive interstitial lung disease-a systemic review and meta-analysis	7
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review	7
Recurrent or persistent salivary gland enlargement in children: When is it Sjögren's?	7
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic art	7
Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure	7
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies	7
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort	7
Correspondence on “Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial” by Ferrero et al	7
Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data	7
Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease	7
Comment on the article by Maguire et al. pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis	7
Autoantibodies to dense-fine-speckled 70 (DFS70) do not necessarily rule out connective tissue diseases	7
Associations between mean simplified disease activity index score and bone mineral density of patient with rheumatoid arthritis in Asian cohort	7
Artificial intelligence in medical imaging is a tool for clinical routine and scientific discovery	7
Insights into suicidal behavior among psoriatic arthritis patients: A systematic review and a genetic linkage disequilibrium analysis	7
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set	7
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus	7